#92: Syntara Phase 2 Success, Geopolitics and Uranium

from Frazis Capital Podcast · host Michael Frazis

Syntara’s highly anticipated Phase 2 results in myelofibrosis—what the data tells us, why the market sold off, and what might come next in terms of funding or partnership.

Episode metadata supplied by the publisher feed · Published Jun 16, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

#92: Syntara Phase 2 Success, Geopolitics and Uranium

0:00 25:06

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Frazis Capital Podcast?

This episode is 25 minutes long.

When was this Frazis Capital Podcast episode published?

This episode was published on June 16, 2025.

Can I download this Frazis Capital Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!